Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antileukotriene agents

R A Tan1, S L Spector

  • 1Allergy Research Foundation, Los Angeles, CA 90026, USA.

Current Opinion in Pulmonary Medicine
|May 1, 1997
PubMed
Summary
This summary is machine-generated.

Antileukotriene agents offer a new, safe, and effective treatment for chronic asthma by targeting leukotrienes. Regular use significantly improves lung function and symptoms in patients with chronic asthma.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Submental Nasal Appearance Scale for the Assessment of Repaired Unilateral Complete Cleft Lip: A Validation Study.

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association·2020
Same author

Leukotrienes and the mechanism by which the LTRAs block their asthma-related effects.

Postgraduate medicine·2009
Same author

Safety of antileukotriene agents in asthma management.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2001
Same author

Subjective and objective markers of treatment response in patients with seasonal allergic rhinitis.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2000
Same author

Lung disease.

Clinical allergy and immunology·2000
Same author

Using antileukotrienes in asthma therapy.

Indian journal of medical sciences·2000
Same journal

Nonsteroid treatment options in (pulmonary) sarcoidosis. When to consider and why?

Current opinion in pulmonary medicine·2026
Same journal

Multidisciplinary approach in cardiac sarcoidosis: to biopsy or not?

Current opinion in pulmonary medicine·2026
Same journal

Low diffusion capacity in pulmonary hypertension.

Current opinion in pulmonary medicine·2026
Same journal

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Current opinion in pulmonary medicine·2026
Same journal

Oxygen therapy in interstitial lung disease - navigating benefit and burden.

Current opinion in pulmonary medicine·2026
Same journal

Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.

Current opinion in pulmonary medicine·2026
See all related articles

Area of Science:

  • Pulmonology
  • Pharmacology
  • Immunology

Background:

  • Asthma involves chronic inflammation driven by mediators like leukotrienes.
  • Leukotrienes contribute to asthma symptoms such as bronchoconstriction and mucus production.

Purpose of the Study:

  • To evaluate antileukotriene agents as a novel therapeutic class for asthma.
  • To assess the efficacy and safety of these agents in managing chronic asthma.

Main Methods:

  • Review of studies on leukotriene synthesis inhibitors and leukotriene receptor antagonists.
  • Analysis of clinical outcomes including pulmonary function and symptoms.

Main Results:

  • Regular use of antileukotriene agents significantly improved pulmonary function.

Related Experiment Videos

  • Clinical symptoms of chronic asthma were markedly reduced with these medications.
  • The agents demonstrated good tolerability in patients.

    • Conclusions:

    • Antileukotriene agents represent a promising new class of asthma medications.
    • These agents offer effective and safe therapeutic options for chronic asthma management.
    • Further long-term studies are warranted to confirm safety and efficacy.